Yewan Park

Yewan Park

Auto-generated profile, based on publicly available information

Yewan Park

Department of Internal Medicine, Kyung Hee University Hospital, School of Medicine, Kyung Hee University, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2020 in Gut
Verified
Journal Article
Closed access
PDF file
MKMinseok Albert Kim
Minseok Albert Kim
Seung Up KimSeung Up Kim
Seung Up Kim
DSDong Hyun Sinn
Dong Hyun Sinn
Jeong Won JangJeong Won Jang
Jeong Won Jang
YLYoung-Suk Lim
Young-Suk Lim
JLJeong-Hoon Lee
Jeong-Hoon Lee
Objective Direct comparison of the clinical outcomes between nucleos(t)ide analogue (NA) discontinuation versus NA continuation has not been performed in patients with chronic hepatitis B who achieved HBsAg-seroclearance. Whether NA discontinuation was as safe as NA continuation after NA-induced surface antigen of HBV (HBsAg) seroclearance was investigated in the present study. Designs This multicentre study included 276 patients from 16 hospitals in Korea who achieved NA-induced HBsAg seroclearance: 131 (47.5%) discontinued NA treatment within 6 months after HBsAg seroclearance (NA discontinuation group) and 145 (52.5%) continued NA treatment (NA continuation group). Primary endpoint was HBsAg reversion and secondary endpoints included serum HBV DNA redetection and development of hepatocellular carcinoma (HCC). Results During follow-up (median=26.9 months, IQR=12.2–49.2 months), 10 patients (3.6%) experienced HBsAg reversion, 6 (2.2%) showed HBV DNA redetection and 8 (2.9%) developed HCC. Compared with NA continuation, NA discontinuation was not associated with HBsAg reversion in both univariable (HR=0.45, 95% CI=0.12 to 1.76, log-rank p=0.24) and multivariable analyses (adjusted HR=0.65, 95% CI=0.16 to 2.59, p=0.54). The cumulative probabilities of HBsAg reversion at 1, 3 and 5 years were 0.8%, 2.3% and 5.0% in the NA discontinuation group, and 1.5%, 6.3% and 8.4% in the NA continuation group, respectively. NA discontinuation was not associated with higher risk of either HBV redetection (HR=0.83, 95% CI=0.16 to 4.16, log-rank p=0.82) or HCC development (HR=0.53, 95% CI=0.12 to 2.23, log-rank p=0.38). Conclusion The discontinuation of NA was not associated with a higher risk of either HBsAg reversion, serum HBV DNA redetection or HCC development compared with NA continuation among patients who achieved HBsAg seroclearance with NA.

30 June 2021 in Hepatology
Verified
Journal Article
Closed access
PDF file
YPYewan Park
Yewan Park
DSDong Hyun Sinn
Dong Hyun Sinn
JOJoo Hyun Oh
Joo Hyun Oh
MGMyung Ji Goh
Myung Ji Goh
KKKyunga Kim
Kyunga Kim
GGGeum‐Youn Gwak
Geum‐Youn Gwak

23 March 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YPYewan Park
Yewan Park
DSDong Hyun Sinn
Dong Hyun Sinn
KKKyunga Kim
Kyunga Kim
GGGeum-Youn Gwak
Geum-Youn Gwak
It is unclear if various types and domains of exercise have an identical effect on non-alcoholic fatty liver disease (NAFLD). Thus, this study aimed to investigate associations of different physical activity domains and muscle strength exercise with NAFLD using a nation-wide cohort database. Adults aged 20–79 years who participated in the Korean National Health and Nutrition Examination Survey between 2014 and 2018 were analyzed. Hepatic steatosis index was used to identify NAFLD. Physical activity was assessed with the Global Physical Activity Questionnaire. Of 21,015 participants, 4942 (23.5%) had NAFLD. Participants with ≥ 150 min/week of total physical activity had a lower risk of NAFLD than those with < 150 min/week (the fully adjusted OR: 0.86, 95% CI 0.78–0.95). When the individual domain of physical activity was assessed, ≥ 150 min/week of recreation activity was associated with a reduced risk of NAFLD (OR: 0.77, 95% CI 0.67–0.88), whereas ≥ 150 min/week of travel or work activity was not. The fully adjusted OR for NAFLD comparing participants with ≥ 2/week to those with < 2/week of muscle strength exercise was 0.83 (95% CI 0.73–0.94). Muscle strength exercise ≥ 2/week showed a lower risk of NAFLD for all levels of total and each specific domains of physical activity except for ≥ 150 min/week of work activity. An increased level of physical activity and muscle strength exercise was associated with a reduced risk of NAFLD, albeit the effect varied depending on domains of physical activity. Thus, physical activity should be differentiated by domains for the management of NAFLD. Muscle strength exercise could also be a good option for individuals who could not perform moderate-to-vigorous physical activity.

31 March 2023 in Gut and Liver
Verified
Journal Article
Open access
PDF file
JCJong-In Chang
Jong-In Chang
JKJung Hee Kim
Jung Hee Kim
DSDong Hyun Sinn
Dong Hyun Sinn
JCJu-Yeon Cho
Ju-Yeon Cho
KKKwang Min Kim
Kwang Min Kim
SPSeung-Woon Paik
Seung-Woon Paik
Jong-In Chang, Jung Hee Kim, Dong Hyun Sinn, Ju-Yeon Cho, Kwang Min Kim, Joo Hyun Oh, Yewan Park, Won Sohn, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, and Seung-Woon Paik. Gut and Liver 2023;17:620-8. https://doi.org/10.5009/gnl220420

21 October 2022 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
YPYewan Park
Yewan Park
DSDong Hyun Sinn
Dong Hyun Sinn
KKKyunga Kim
Kyunga Kim
GGGeum‐Youn Gwak
Geum‐Youn Gwak

17 August 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
WCWon Joon Choi
Won Joon Choi
GKGi-Ae Kim
Gi-Ae Kim
JPJaewon Park
Jaewon Park
SJSangmi Jang
Sangmi Jang
WJWoo Jin Jung
Woo Jin Jung
EJEun Sun Jang
Eun Sun Jang
Choi WJ, et al. J Korean Med Sci. 2022 Aug;37(33):e255. https://doi.org/10.3346/jkms.2022.37.e255